147 related articles for article (PubMed ID: 23830696)
1. Three dimensional structure of a bacterial α-l-fucosidase with a 5-membered iminocyclitol inhibitor.
Wright DW; Moreno-Vargas AJ; Carmona AT; Robina I; Davies GJ
Bioorg Med Chem; 2013 Aug; 21(16):4751-4. PubMed ID: 23830696
[TBL] [Abstract][Full Text] [Related]
2. Exploiting the hydrophobic terrain in fucosidases with aryl-substituted pyrrolidine iminosugars.
Hottin A; Wright DW; Davies GJ; Behr JB
Chembiochem; 2015 Jan; 16(2):277-83. PubMed ID: 25427942
[TBL] [Abstract][Full Text] [Related]
3. Structural and thermodynamic analyses of α-L-fucosidase inhibitors.
Lammerts van Bueren A; Popat SD; Lin CH; Davies GJ
Chembiochem; 2010 Sep; 11(14):1971-4. PubMed ID: 20665773
[No Abstract] [Full Text] [Related]
4. Unraveling the substrate recognition mechanism and specificity of the unusual glycosyl hydrolase family 29 BT2192 from Bacteroides thetaiotaomicron.
Guillotin L; Lafite P; Daniellou R
Biochemistry; 2014 Mar; 53(9):1447-55. PubMed ID: 24527659
[TBL] [Abstract][Full Text] [Related]
5. Development of fucosyltransferase and fucosidase inhibitors.
Tu Z; Lin YN; Lin CH
Chem Soc Rev; 2013 May; 42(10):4459-75. PubMed ID: 23588106
[TBL] [Abstract][Full Text] [Related]
6. Differences in the substrate specificities and active-site structures of two α-L-fucosidases (glycoside hydrolase family 29) from Bacteroides thetaiotaomicron.
Sakurama H; Tsutsumi E; Ashida H; Katayama T; Yamamoto K; Kumagai H
Biosci Biotechnol Biochem; 2012; 76(5):1022-4. PubMed ID: 22738979
[TBL] [Abstract][Full Text] [Related]
7. α-L-fucosidase inhibition by pyrrolidine-ferrocene hybrids: rationalization of ligand-binding properties by structural studies.
Hottin A; Wright DW; Steenackers A; Delannoy P; Dubar F; Biot C; Davies GJ; Behr JB
Chemistry; 2013 Jul; 19(29):9526-33. PubMed ID: 23740878
[TBL] [Abstract][Full Text] [Related]
8. Expanding the library of divalent fucosidase inhibitors with polyamino and triazole-benzyl bridged bispyrrolidines.
Hottin A; Carrión-Jiménez S; Moreno-Clavijo E; Moreno-Vargas AJ; Carmona AT; Robina I; Behr JB
Org Biomol Chem; 2016 Mar; 14(12):3212-20. PubMed ID: 26906450
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of all-cis 2,5-imino-2,5-dideoxy-fucitol and its evaluation as a potent fucosidase and galactosidase inhibitor.
Ak A; Prudent S; LeNouën D; Defoin A; Tarnus C
Bioorg Med Chem Lett; 2010 Dec; 20(24):7410-3. PubMed ID: 21050758
[TBL] [Abstract][Full Text] [Related]
10. Stereoselective synthesis of (2S,3S,4R,5S)-5-methylpyrrolidine-3,4-diol derivatives that are highly selective alpha-L-fucosidase inhibitors.
Moreno-Vargas AJ; Carmona AT; Mora F; Vogel P; Robina I
Chem Commun (Camb); 2005 Oct; (39):4949-51. PubMed ID: 16205810
[TBL] [Abstract][Full Text] [Related]
11. Spirocyclopropyl pyrrolidines as a new series of alpha-L-fucosidase inhibitors.
Laroche C; Behr JB; Szymoniak J; Bertus P; Schütz C; Vogel P; Plantier-Royon R
Bioorg Med Chem; 2006 Jun; 14(12):4047-54. PubMed ID: 16488612
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the reaction coordinate of alpha-L-fucosidases: a combined structural and quantum mechanical approach.
Lammerts van Bueren A; Ardèvol A; Fayers-Kerr J; Luo B; Zhang Y; Sollogoub M; Blériot Y; Rovira C; Davies GJ
J Am Chem Soc; 2010 Feb; 132(6):1804-6. PubMed ID: 20092273
[TBL] [Abstract][Full Text] [Related]
13. The 'mirror-image' postulate as a guide to the selection and evaluation of pyrrolidines as α-l-fucosidase inhibitors.
Stocker BL; Jongkees SA; Win-Mason AL; Dangerfield EM; Withers SG; Timmer MS
Carbohydr Res; 2013 Feb; 367():29-32. PubMed ID: 23295913
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel pyrrolidine 3,4-diol derivatives as inhibitors of alpha-L-fucosidases.
Moreno-Clavijo E; Carmona AT; Vera-Ayoso Y; Moreno-Vargas AJ; Bello C; Vogel P; Robina I
Org Biomol Chem; 2009 Mar; 7(6):1192-202. PubMed ID: 19262940
[TBL] [Abstract][Full Text] [Related]
15. Glycosidase-substrate interactions analysis by STD-NMR spectroscopy: study of alpha-L-fucosidase.
Berteau O; Sandström C; Bielicki J; Anson DS; Kenne L
J Am Chem Soc; 2003 Dec; 125(50):15296-7. PubMed ID: 14664566
[TBL] [Abstract][Full Text] [Related]
16. Synthetic and Crystallographic Insight into Exploiting sp
Coyle T; Wu L; Debowski AW; Davies GJ; Stubbs KA
Chembiochem; 2019 Jun; 20(11):1365-1368. PubMed ID: 30663832
[TBL] [Abstract][Full Text] [Related]
17. Discovery of picomolar slow tight-binding inhibitors of alpha-fucosidase.
Chang CF; Ho CW; Wu CY; Chao TA; Wong CH; Lin CH
Chem Biol; 2004 Sep; 11(9):1301-6. PubMed ID: 15380190
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of alpha-fucosidase inhibition by iminocyclitols with K(i) values in the micro- to picomolar range.
Wu HJ; Ho CW; Ko TP; Popat SD; Lin CH; Wang AH
Angew Chem Int Ed Engl; 2010; 49(2):337-40. PubMed ID: 19967696
[No Abstract] [Full Text] [Related]
19. Synthesis and biological evaluation of N-(2-fluorophenyl)-2β-deoxyfuconojirimycin acetamide as a potent inhibitor for α-l-fucosidases.
Kato A; Okaki T; Ifuku S; Sato K; Hirokami Y; Iwaki R; Kamori A; Nakagawa S; Adachi I; Kiria PG; Onomura O; Minato D; Sugimoto K; Matsuya Y; Toyooka N
Bioorg Med Chem; 2013 Nov; 21(21):6565-73. PubMed ID: 24026016
[TBL] [Abstract][Full Text] [Related]
20. Harnessing pyrrolidine iminosugars into dimeric structures for the rapid discovery of divalent glycosidase inhibitors.
Carmona AT; Carrión-Jiménez S; Pingitore V; Moreno-Clavijo E; Robina I; Moreno-Vargas AJ
Eur J Med Chem; 2018 May; 151():765-776. PubMed ID: 29674295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
